A real-life cohort of antifibrotic-treated non-IPF progressive pulmonary fibrosis patients

被引：0
|
作者：
Renner, A. [1 ,2 ]
Vertanen, E. [2 ]
Sutinen, E. [2 ,3 ,4 ]
Ainola, M. [2 ,3 ,4 ]
Myllaerniemi, M. [2 ,3 ,4 ]
Hollmen, M. [2 ,3 ,4 ]
机构：
[1] Med Univ Vienna, Pulmonol, Vienna, Austria
[2] Univ Helsinki, Individualized Drug Therapy Res Program, Fac Med, Helsinki, Finland
[3] Univ Helsinki, Helsinki, Finland
[4] Helsinki Univ Hosp, Dept Pulmonol, Helsinki, Finland
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2024年 / 136卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P63
引用
收藏
页码：S552 / S552
页数：1
相关论文
共 50 条
  • [21] MMP28 Is Upregulated in Idiopathic Pulmonary Fibrosis (IPF) Epithelium and Is a Promising Biomarker to Distinguish IPF from Non-IPF Patients
    Maldonado, M.
    Buendia, I.
    Vicens Zygmunt, V.
    Planas, L.
    Molina Molina, M.
    Selman, M.
    Pardo, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] Real-life efficacy of Pirfenidone in a cohort of patients with IPF in Northern Greece
    Kotoulas, Serafim Chrysovalantis
    Fouka, Evangelia
    Organtzis, Ioannis
    Pitsiou, Georgia
    Papaioannou, Antonios
    Euthymiou, Christoforos
    Stanopoulos, Ioannis
    Mourouzidou, Violetta
    Kontakiotis, Theodoros
    Papakosta, Despoina
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [23] MULTICENTER STUDY INVESTIGATING THE IMPACT OF DEEP LEARNING-BASED UIP CLASSIFIER ON IDENTIFYING UNDIAGNOSED IPF AND NON-IPF PROGRESSIVE PULMONARY FIBROSIS
    Patel, Avignat
    Bhatt, Padmanabh
    Thomas, Richard
    Hoang, Hai
    Aglan, Mostafa
    Ahmed, Alaaeldin
    Arora, Shreya
    Vaz, Victor Ren
    Guillen, Ramon
    Wald, Christoph
    Rieger-Christ, Kimberly
    Liesching, Timothy N.
    Pinto-Plata, Victor M.
    Thomson, Carey C.
    Gazourian, Lee
    CHEST, 2024, 166 (04) : 6398A - 6399A
  • [24] Longitudinal Comparison of Anxiety and Depression Between Idiopathic Pulmonary Fibrosis (IPF) and Non-IPF Interstitial Lung Disease: A Prospective Cohort Study
    Bae, W.
    Cho, J.
    Lee, J.
    Park, Y.
    Lee, C.
    Lee, S.
    Yim, J.
    Yoo, C.
    Kim, Y.
    Han, S.
    Choi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [25] Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease
    Opuni, Kwabena
    Kreuter, Michael
    Quaresma, Manuel
    Wijsenbeek, Marlies
    Olson, Amy
    Fischer, Aryeh
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 782 - 782
  • [26] Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease
    Kreuter, M.
    Olson, A.
    Fischer, A.
    Bendstrup, E.
    Mounir, B.
    Zouad-Lejour, L.
    Wells, C. D.
    Quaresma, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] End-of-life of patients with idiopathic pulmonary fibrosis treated with antifibrotic therapy
    Sato, Makiko
    Koga, Yasuhiko
    Hachisu, Yoshimasa
    Takehara, Kazutaka
    Wakamatsu, Ikuo
    Shin, Yuki
    Saito, Haruka
    Yatomi, Masakiyo
    Tsurumaki, Hiroaki
    Sunaga, Noriaki
    Maeno, Toshitaka
    Hisada, Takeshi
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [28] Effects of Antifibrotic Therapy in the Real-world Progressive Pulmonary Fibrosis
    Niitsu, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] SWITCHING ANTIFIBROTIC MEDICATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): A DESCRIPTIVE STUDY
    Sun, Yihao
    Girard, Jennifer
    Dsouza, Kevin G.
    Luckhardt, Tracy
    Kulkarni, Tejaswini
    CHEST, 2023, 164 (04) : 3089A - 3090A
  • [30] MAINTAINING PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) ON ANTIFIBROTIC THERAPY; THE NURSES' CHALLENGE
    Burge, G. A.
    Alldrick, H.
    Briggs, E.
    Neighbour, K.
    Burge, P. S.
    Walters, G. I.
    THORAX, 2017, 72 : A167 - A168
12345